Canopy Growth (TSE:WEED) Trading Down 1.3% – What’s Next?

Shares of Canopy Growth Corp (TSE:WEEDGet Free Report) fell 1.3% on Thursday . The stock traded as low as C$1.46 and last traded at C$1.48. 1,193,758 shares changed hands during mid-day trading, a decline of 45% from the average session volume of 2,179,330 shares. The stock had previously closed at C$1.50.

Analyst Ratings Changes

Several research firms have recently weighed in on WEED. ATB Cormark Capital Markets raised Canopy Growth from a “sector perform” rating to an “outperform” rating and set a C$1.40 price objective for the company in a report on Tuesday, March 17th. Canaccord Genuity Group set a C$2.00 price target on Canopy Growth and gave the stock a “speculative buy” rating in a report on Friday, March 27th. Finally, Sanford C. Bernstein decreased their price target on Canopy Growth from C$5.30 to C$2.50 in a report on Wednesday, January 14th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of C$1.97.

View Our Latest Stock Analysis on WEED

Canopy Growth Trading Down 1.3%

The company has a quick ratio of 2.32, a current ratio of 5.34 and a debt-to-equity ratio of 35.93. The company has a fifty day moving average of C$1.47 and a two-hundred day moving average of C$1.60. The stock has a market capitalization of C$625.77 million, a price-to-earnings ratio of -0.80, a P/E/G ratio of -0.01 and a beta of 1.61.

Canopy Growth Company Profile

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands.

Read More

Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.